KRAS-driven Tumorigenesis and KRAS-driven Therapy in Pancreatic Adenocarcinoma.
Sign Up to like & getrecommendations! Published in 2024 at "Molecular cancer therapeutics"
DOI: 10.1158/1535-7163.mct-23-0519
Abstract: Pancreatic ductal adenocarcinoma (PDAC) is associated with significant morbidity and mortality and is projected to be the second leading cause of cancer-related deaths by 2030. Mutations in KRAS are found in the vast majority of… read more here.
Keywords: adenocarcinoma; driven therapy; tumorigenesis kras; driven tumorigenesis ... See more keywords